TrialBritish journal of cancer2013

Combination neratinib (HKI-272) and paclitaxel therapy in patients with HER2-positive metastatic breast cancer.

L W-C Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.